InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,059.43
(
1.39%
)
Post# of 252591
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 45
Posts 4605
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 235500

Sunday, 11/08/2020 8:15:35 PM

Sunday, November 08, 2020 8:15:35 PM

Post# of 252591
Ascribing negative value to a biotech pipeline is nothing new or uncommon, as you know. (Wasn’t there a table of biotechs trading below cash at one time). It’s not hard to waste money in drug development. What is surprising though is a company like ENTA not getting any benefit of the doubt in light of their track record.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up